Witnessing the stock’s movement on the chart, on Thursday, Exact Sciences Corp. (NASDAQ: EXAS) set off with pace as it heaved 4.96% to $44.00, before settling in for the price of $41.92 at the close. Taking a more long-term approach, EXAS posted a 52-week range of $41.08-$100.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 43.88%. Meanwhile, its Annual Earning per share during the time was 4.59%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -1.23%. This publicly-traded company’s shares outstanding now amounts to $184.53 million, simultaneously with a float of $182.22 million. The organization now has a market capitalization sitting at $8.12 billion. At the time of writing, stock’s 50-day Moving Average stood at $54.09, while the 200-day Moving Average is $63.03.
Exact Sciences Corp. (EXAS) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Diagnostics & Research industry. Exact Sciences Corp.’s current insider ownership accounts for 1.25%, in contrast to 89.66% institutional ownership. According to the most recent insider trade that took place on May 01 ’24, this organization’s President and CEO sold 1,155 shares at the rate of 60.15, making the entire transaction reach 69,473 in total value, affecting insider ownership by 1,156,191. Preceding that transaction, on May 01 ’24, Company’s Chief Commercial Officer sold 136 for 60.15, making the whole transaction’s value amount to 8,180. This particular insider is now the holder of 47,042 in total.
Exact Sciences Corp. (EXAS) Earnings and Revenue Records
Exact Sciences Corp.’s EPS decrease for this current 12-month fiscal period is -1.23% and is forecasted to reach -0.02 in the upcoming year.
Exact Sciences Corp. (NASDAQ: EXAS) Trading Performance Indicators
Let’s observe the current performance indicators for Exact Sciences Corp. (EXAS). It’s Quick Ratio in the last reported quarter now stands at 1.45. The Stock has managed to achieve an average true range (ATR) of 2.27. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.20.
In the same vein, EXAS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.32, a figure that is expected to reach -0.33 in the next quarter, and analysts are predicting that it will be -0.02 at the market close of one year from today.
Technical Analysis of Exact Sciences Corp. (EXAS)
Going through the that latest performance of [Exact Sciences Corp., EXAS]. Its last 5-days volume of 2.63 million indicated improvement to the volume of 2.56 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 42.17% While, its Average True Range was 2.07.
Raw Stochastic average of Exact Sciences Corp. (EXAS) in the period of the previous 100 days is set at 7.57%, which indicates a major fall in contrast to 47.78% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 40.16% that was lower than 50.06% volatility it exhibited in the past 100-days period.
